secwatch.observer — SEC 8-K summary
======================================

Issuer:     Cyclerion Therapeutics, Inc. (CYCN)
CIK:        0001755237
Form:       8-K
Filed at:   2022-06-03T23:59:59+00:00
Accession:  0000950170-22-011148
Event type: other_material
Sentiment:  negative
Materiality: 0.65
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Cyclerion receives Nasdaq deficiency notice for bid price below $1; 180-day cure period to Nov 28, 2022
--------------------------------------------------------------------------------

- Received Nasdaq deficiency letter on June 1, 2022, for failing minimum $1 bid price for 30 consecutive business days.
- Has until November 28, 2022, to regain compliance with bid price closing at $1 for 10 consecutive days.
- May transfer to Nasdaq Capital Market or effect a reverse stock split if needed to cure the deficiency.
- No assurance of regaining compliance; failure could lead to delisting and appeal process.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1755237/000095017022011148/0000950170-22-011148-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1755237/000095017022011148/cycn-20220603.htm
  HTML page:      https://secwatch.observer/filing/0000950170-22-011148

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer